"I encourage ladies to converse with their medical services supplier about their manifestations and find a therapy choice that is ideal for them, very much like Linda did." Indication INTRAROSA vaginal additions are a professionally prescribed medication utilized in ladies after menopause to get moderate serious agony during sex brought about by changes in and around the vagina that occur with menopause. Significant Safety Information INTRAROSA is contraindicated in ladies with undiscovered strange genital bleeding.Estrogen is a metabolite of prasterone. Utilization of exogenous estrogen is contraindicated in ladies with a known or associated history with bosom malignant growth. INTRAROSA has not been considered in ladies with a background marked by bosom cancer.In four 12-week randomized, fake treatment controlled clinical preliminaries, the most well-known unfriendly response with a rate ?2 percent was vaginal release. In one 52-week open-mark clinical preliminary, the most widely recognized antagonistic responses with an occurrence ?2 percent were vaginal release and strange Pap smear.You are urged to report negative symptoms of physician recommended medications to the FDA.
This promotion has ended.
The winner will be announced soon.